Welcome to the Department of Radiation Sciences

For English, Please visit the English website

Department of Radiation Sciences comprises the subject’s diagnostic radiology, oncology, radiation physics and medical technology.
Institute belongs to the Faculty of Medicine at Umeå University.
In addition to the training of medical doctors and radiology nurses in the Medical Faculty, the department also has extensive activities in the Faculty of Technology, including the training of medical physicists and engineers. Graduate and undergraduate education as well as research are conducted in these subjects.
In addition to the education of physicians, the department has extensive courses at the Faculty of Science and Technology where we teach future hospital physicists and engineers in biomedical engineering.

Laboratories and centers where several of our researchers are active

We are working closely with the University hospital, especially the clinics: The Cancer Clinic, The department of Radiology and Nuclear medicine The Center for Biomedical Engineering and Radiation Physics (CMTS).

News from the department

The Wallenberg Centre of Molecular Medicine at Umeå University (WCMM) is announcing for outstanding researchers, to be positioned within our research enviroment under the the following subject of cancer, neuroscience or metabolic disorders. wcmm.umu.se

The International Day of Radiology (IDoR) will be celebrated for the sixth time onNovember 8, this year focusing on emergency radiology
Read more here

The Swedish Research Counsil has in October 2017, approved grant to 3 researchers at the department:
Bethany van Guelpen, 2 400 000 SEK, project: Riskprediktion och tidig upptäckt av tjock- och ändtarmscancer cancer; en integrativ molekylärepidemiologisk approach
Daniel Öhlund, 6 000 000 SEK, project: Tumörstromat som läkemedelsmål vid pankreascancer
Anders Wåhlin, 3 200 000 SEK, project: Förstorade artärpulsationer, nedsatt kärlfunktion och skador på hjärnans funktionella nätverk - nya metoder för undersökningar av ett patologiskt händelseförlopp

Nina Karalija
I am a postdoc at diagnostic radiology in Professor Lars Nyberg’s group. My background consist of a master of science in chemical engineering, and a doctoral thesis in neuroscience.
My previous and present research has focused on functions regulated by the dopamine system. At present, I am part of the Cognition, Brain, and Aging (COBRA) project, which aims at evaluating the link between dopamine system integrity and cognitive performance in normal aging.
The dopamine system is a particularly age-sensitive network implicated in cognitive processes. Consequently, different routes of cognitive aging may depend on the status of the dopamine system. The COBRA cohort consists of 181 healthy, older adults that have undergone positron emission tomography to assess dopamine D2-receptor availability, magnetic resonance imaging for measures of brain structure and function, and broad-ranged cognitive assessment.
I was recently awarded a two-year postdoc scholarship from the Swedish Brain Foundation. The project will examine effects of genetic variation on inter-individual differences in dopamine measures and cognitive performance in the COBRA-sample.
This study has the potential to map predictors of age-related cognitive decline. Such knowledge is needed as severe decline compromises the well-being for a large number of individuals.

Phd/MD Danel Öhlund,
I have a specific interest in, and previous experiences of, pancreatic cancer microenvironment research. In my thesis I studied the role of the tumor stroma as a prognostic and diagnostic marker, and as a regulator of pancreatic tumor growth. We found that the increased expression and deposition of extracellular matrix (ECM) proteins in tumor tissue was reflected in the circulation, and that increased levels of ECM-derived protein fragments in the circulation correlated with poor prognosis. During my postdoctoral period in the Tuveson Laboratory at Cold Spring Harbor, New York, I continued to study the tumor microenvironment, focusing on the composition of the tumor stroma, and how interactions between cancer cells and tumor stroma impact on tumor progression and drug resistance. During this period, I developed a new organotypic co-culture system for studying stromal interactions, and I was also trained in using genetic engineered mouse models of pancreatic cancer.
I have recently been selected for an assistant professorship at Wallenberg Center for Molecular Medicine (WCMM) at Umeå University, and as a WCMM fellow I will continue to work on the tumor microenvironment. I will focus on deciphering the functional heterogeneity of stromal components within the tumor microenvironment, aiming to identify drugable stromal interactions driving tumor progression and to develop inhibitors to these interactions.

For men with intermediate risk prostate cancer, side effects at two years following radiation therapy (RT) were comparable for extremely-hypofractionated treatment, which was delivered in seven fractions across two and a half weeks, and conventional treatment of 39 fractions across eight weeks, according to research presented by professor Anders Widmark at the
58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

My name is Anneli Sundkvist (previously Marklund). I graduated in Medicine in June 20116 and have now started my research and medical internship at Norrlands University Hospital. I will be working with MD, PhD Bethany van Guelpen and PhD Sophia Harlid (Department of Radiation Sciences) on a project focusing on finding early biomarkers for colorectal cancer in blood. The project involves metabolomics, biomarkers for inflammation, and analysis of methylation in white blood cells.
After receiving my PhD in Chemistry at Umeå University in 2006, I have been working with research at the department of Environmental Chemistry and at the Department of Public Health and Clinical Medicine. During my Doctoral studies I were to investigate levels, distribution patterns and sources of organophosphorus (OPs) flame retardants and plasticizers in different environmental compartments. Indoor and outdoor environments, biological samples and human exposure to OPs were investigated in order to generate data which may be used for risk assessments. An additional aim was to develop analytical methods which could be utilized to analyse OPs in different matrixes.

In September 2016, PhD Anton Lindström begun his research and medical internship at Norrlands University Hospital. He will be working I collaboration with PhD Maria Sandström and PhD Tufve Nyholm (Department of Radiation Sciences). Their project involves detecting treatment response in glioma tumors using multivariate data analysis (MDA) of magnetic resonance-images.
Anton was awarded his PhD in Chemistry in 2009 and continued with his Post Doc research at the Department of Radiation Sciences Umeå University until 2012. In 2012 he was also accepted for medical studies at Umeå University and graduated in 2016, and alongside his medical studies he has continued with research focused on characterization of mouse glioma tumors using near infrared spectroscopy.
During his academic career his research has been strongly influenced by the application of tools for multivariate data analysis (MDA). In his PhD studies, MDA was applied for exploring the interaction between the active-site of proteins and drug-like ligands. And in his Post Doc work, MDA was used for the design of optimal MRI sequence settings for the enhancement of bone signal.
Anton is very happy to be part of the research group and is estimated to continue with his joint research and clinical internship at least until September 2019.

Anna Rieckmann
has received 1.5 Million Euros for a 5-year research project from an ERC Starting Grant.
ERC Starting Grants are awarded by the European Commission to young talented researchers with a promising track-record, with the aim of encouraging them to become independent research leaders. Anna joined the Department of Radiation Sciences (Diagnostic Radiology) when she returned to Sweden after a 3-year post-doc at Harvard University in the US. In her new research project, Anna will use simultaneous PET/MR to study the metabolic basis of the fMRI signal during cognitive control.
She hopes to gain new insights into the neural basis of cognitive functioning in early adulthood and aging.

My name is Sophia Harlid and I recently started full time as a senior research engineer at the department of radiation Sciences. I received my PhD in molecular epidemiology at Lund University in 2011 and after that I spent about 5 years at the National Institute of Health in the US as a postdoctoral fellow.
During my PhD I focused on evaluating genetic risk factors for breast cancer while incorporating environmental components. As a postdoc I investigated the effect of the environment on DNA methylation in blood and tissue, and how external exposures can increase cancer risk through epigenetic modifications. I currently work with Dr. Bethany Van Guelpen at Umeå University on a project focusing on biomarker discovery in early colorectal cancer.


The most recent publications from our department

The effects of clinical and sociodemographic factors on survival, resource use and lead times in patients with high-grade gliomas : a population-based register study


Density Estimation of Grey-Level Co-Occurrence Matrices for Image Texture Analysis


Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania


Treatment and survival of rectal cancer patients over the age of 80 years : a EURECCA international comparison


Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma


Bone remodeling in relation to androgen receptor activity in prostate cancer bone metastases


An Exercise Intervention to Unravel the Mechanisms Underlying Insulin Resistance in a Cohort of Black South African Women : Protocol for a Randomized Controlled Trial and Baseline Characteristics of Participants


Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic : Results from a prematurely terminated randomized phase II trial


Technical note : adapting a GE SIGNA PET/MR scanner for radiotherapy


Glioma-related seizures in relation to histopathological subtypes : a report from the glioma international case-control study


Page Editor: Maria Wing

Print page

Contact Information

Diagnostic Radiology
Umeå University
SE-901 87 Umeå 

Visiting Address
Building 3A, University Hospital

Tel:  +46-90 785 00 00

Fax:  +46-90 12 23 03

Contact Information

Umeå University
SE-901 87 Umeå 

Visiting Address
Buildings 6M, 3B, 10C, University Hospital

Tel:  +46-90 785 00 00


Contact Information

Radiation Physics
Umeå University
901 87 Umeå 

Visiting Address
Building 10C, 27 University Hospital

Tel:  +46-90 785 00 00